Icon Plc (ICLR) is a publicly traded Healthcare sector company. As of May 21, 2026, ICLR trades at $115.09 with a market cap of $8.69B and a P/E ratio of 0.00. ICLR moved +1.51% today. Year to date, ICLR is -41.75%; over the trailing twelve months it is -12.86%. Its 52-week range spans $66.57 to $303.69. Analyst consensus is buy with an average price target of $135.57. Rallies surfaces ICLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ICON stock gains as audit investigation wraps; restatement scope looks contained: ICON shares are rising after the company said its Audit Committee completed an investigation into accounting practices and controls, with revenue overstatements below the previously disclosed 2% cap. ICON also reaffirmed no impact to customers, operations, or cash flow, and said audited results and restated filings are expected in the coming weeks.
| Metric | Value |
|---|---|
| Price | $115.09 |
| Market Cap | $8.69B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $303.69 |
| 52-Week Low | $66.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover ICLR: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $135.57.